How are they Solving it?
At Ubique, we have developed a Platform, improved to shorten R&D development time, to design synthetic peptides that replace recombinant proteins in antibody detection tests.
Our approach is based on the synthetic peptide’s library design using immunoinformatic, efficacy detection testing against patients’ sera, and peptide chemical synthesis in bulk. The obtained peptides have the unique characteristics of being highly specific, sensitive, and thermostable. They are also ready to be included within most commercially available tests. Our products provide efficient multiplex diagnostics, allowing us to create specific Solutions to detect multiple infectious diseases at the same time, saving both time and money, while reducing the diagnostic gap in the world.